インデックス付き
  • Jゲートを開く
  • Genamics JournalSeek
  • アカデミックキー
  • ジャーナル目次
  • グローバル インパクト ファクター (GIF)
  • 中国国家知識基盤 (CNKI)
  • ウルリッヒの定期刊行物ディレクトリ
  • レフシーク
  • ハムダード大学
  • エブスコ アリゾナ州
  • OCLC-WorldCat
  • パブロン
  • ジュネーブ医学教育研究財団
  • ユーロパブ
  • Google スカラー
このページをシェアする
ジャーナルチラシ
Flyer image

概要

Spectrophotometric Determination of Some Antibiotics Using Bromophenol Blue as Ion Pair Reagent

Ravin Jugade and Mrudul Keskar

Objective: Simple and rapid methods have been developed for the determination of azithromycin, sparfloxacin and cephalexin monohydrate in bulk and pharmaceutical formulations. Method: These methods were based on the formation of bluish-green ion pair complexes of these antibiotics with bromophenol blue (BPB). Acetonitrile was used as a solvent for azithromycin and sparfloxacin whereas methanolacetonitrile medium for cephalexin monohydrate. Results: 2:1 complexes were formed between the drug and reagent almost instantaneously with absorption maxima 595 nm, 620 nm, 600 nm for the three drugs respectively. Different parameters such as effect of time, effect of reagent concentration were optimised. Under optimum conditions, calibration curves were found to be linear over the range of 0-50 μg mL-1 for azithromycin, 10-80 μg mL-1 for sparfloxacin and 10-170 μg mL-1 for cephalexin monohydrate respectively. The detection limits were found to be 0.10 μg mL-1, 0.21 μg mL-1 and 1.69 μg mL-1 with Sandell’s sensitivity 0.0559 μg cm-2, 0.1034 μg cm-2 and 1.3920 μg cm-2 respectively for the three drugs. Stability constant (log K) was found to be 6.19 ± 0.04, 5.00 ± 0.07 and 4.05 ± 0.05 showing high stability of the complexes. Molar absorptivity was found to be 1.369×104 L mol-1 cm-1, 3.774×103 L mol-1 cm-1 and 2.620×102 L mol-1 cm-1 with Gibb’s free energy change -2.725×103 kJ mol-1, -2.393×103 kJ mol-1 and -1.938×103 kJ mol-1. These methods were subjected to analytical quality control. Accuracy, precision, recovery and interference studies have been carried out. Conclusion: The proposed methods were successfully applied to the determination of these drugs in their pharmaceutical formulations and human urine samples.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません